Revenue
119 thousand USD
2023 Q3 · USD
Exact inputs and evidence
- Revenue: 118599 USD Source
29 filing records in this dataset, filed from 2000-08-21 to 2024-02-16. Reported financial figures are available; chart coverage varies by period.
119 thousand USD
2023 Q3 · USD
-632.56%
2023 Q3 · %
-267 thousand USD
2023 Q3 · USD
19952732 USD
506357952 shares
-2.99% · -15.6 million shares
Year-over-year change in reported shares. Splits, issuance and buybacks can affect this figure; it does not isolate employee compensation or economic dilution.
The four most recent complete quarters added together. This gives a full-year view that includes the latest quarterly results.
4.64 million USD
2022-07-01 – 2023-06-30
6.89 million USD
2022-07-01 – 2023-06-30
-1.97 million USD
2022-07-01 – 2023-06-30
Includes later revisions to earlier periods. Annual charts exclude incomplete years.
Latest filing recorded: 2024-02-16.
Financial data available through: 2022-09-30.
Coverage describes values retained in this snapshot. Missing values are not zero; loading limits are reported separately.
Latest complete year compared with the corresponding period one year earlier. These are measured changes; they do not establish their business causes.
Prior period
USD 650,515
–
Current period
USD 2.14 million
–
2138010 − 650515 = 1487495 USD
650515 USD · 2020-10-01 – 2021-09-30
Inspect prior input Prior source2138010 USD · 2021-10-01 – 2022-09-30
Inspect current input Current sourceThe citation records this snapshot. The page link may show a newer release later.
Prior period
−USD 6.81 million
–
Current period
−USD 4.88 million
–
-4884468 − -6808154 = 1923686 USD
-6808154 USD · 2020-10-01 – 2021-09-30
Inspect prior input Prior source-4884468 USD · 2021-10-01 – 2022-09-30
Inspect current input Current sourceThe citation records this snapshot. The page link may show a newer release later.
Prior period
−USD 3.72 million
–
Current period
−USD 2.09 million
–
-2088304 − -3720267 = 1631963 USD
-3720267 USD · 2020-10-01 – 2021-09-30
Inspect prior input Prior source-2088304 USD · 2021-10-01 – 2022-09-30
Inspect current input Current sourceThe citation records this snapshot. The page link may show a newer release later.
Comparable inputs unavailable for: Capital expenditure.
How a period’s revenue divides into costs and what remains as profit. Items marked Derived are calculated by subtraction from reported figures.
| Period | Revenue | Operating costs | Operating income | Tax, interest and other | Net income | Free cash flow | Source |
|---|---|---|---|---|---|---|---|
| 2020 2019-10-01 – 2020-09-30 | 1149880 | 4867340 Derived | -3717460 | 5445869 Derived | -9163329 | Unavailable | Source
|
| 2021 2020-10-01 – 2021-09-30 | 650515 | 6021844 Derived | -5371329 | 1436825 Derived | -6808154 | Unavailable | Source
|
| 2022 2021-10-01 – 2022-09-30 | 2138010 | 6054824 Derived | -3916814 | 967654 Derived | -4884468 | Unavailable | Source
|
Amounts are exact, in USD.
Sales over time and how quickly they are changing.
Revenue reported for each complete financial period.
| Period | Series | Value(USD) | Source evidence |
|---|---|---|---|
| 2020 | Revenue | 1149880 |
|
| 2021 | Revenue | 650515 |
|
| 2022 | Revenue | 2138010 |
|
Change in revenue from the same financial period one year earlier.
| Period | Series | Value | Source evidence |
|---|---|---|---|
| 2020 | Year over year | No prior comparable period |
|
| 2021 | Year over year | -43.4% |
|
| 2022 | Year over year | 228.7% |
|
How much revenue becomes profit, and how much cash operations generate.
Operating income, net income and free cash flow as a share of revenue.
| Period | Series | Value | Source evidence |
|---|---|---|---|
| 2020 | Operating margin | -323.3% |
|
| 2021 | Operating margin | -825.7% |
|
| 2022 | Operating margin | -183.2% |
|
| 2020 | Net margin | -796.9% |
|
| 2021 | Net margin | -1,046.6% |
|
| 2022 | Net margin | -228.5% |
|
| 2020 | Free cash flow margin | Not reported |
|
| 2021 | Free cash flow margin | Not reported |
|
| 2022 | Free cash flow margin | Not reported |
|
Cash generated by the company’s normal business operations.
| Period | Series | Value(USD) | Source evidence |
|---|---|---|---|
| 2020 | Operating cash flow | -2497601 |
|
| 2021 | Operating cash flow | -3720267 |
|
| 2022 | Operating cash flow | -2088304 |
|
Operating cash flow minus capital expenditure for the same period and unit.
| Period | Series | Value(USD) | Source evidence |
|---|---|---|---|
| 2020 | Free cash flow | Unavailable |
|
| 2021 | Free cash flow | Unavailable |
|
| 2022 | Free cash flow | Unavailable |
|
Liabilities and short-term ability to meet obligations at each period end.
Total liabilities as a share of total assets.
| Period | Series | Value | Source evidence |
|---|---|---|---|
| 2020 | Liabilities / assets | 704.3% |
|
| 2021 | Liabilities / assets | 667.5% |
|
| 2022 | Liabilities / assets | 173% |
|
Current assets divided by current liabilities.
| Period | Series | Value | Source evidence |
|---|---|---|---|
| 2020 | Current assets / current liabilities | 0.09× |
|
| 2021 | Current assets / current liabilities | 0.09× |
|
| 2022 | Current assets / current liabilities | 0.18× |
|
Compare reported profit with operating cash and capital spending. Free cash flow is calculated as operating cash flow minus capital expenditure when both exact, consolidated amounts match the same period and unit.
| Period | Net income | Operating cash flow | Capital expenditure | Free cash flow |
|---|---|---|---|---|
| 2020 2019-10-01 – 2020-09-30 | −USD 9.16 million Exact valueExact value: -9163329 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | −USD 2.5 million Exact valueExact value: -2497601 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | Unavailable Not reported for this period. | Unavailable Free cash flow cannot be calculated because Capital expenditure is unavailable for this period. |
| 2021 2020-10-01 – 2021-09-30 | −USD 6.81 million Exact valueExact value: -6808154 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | −USD 3.72 million Exact valueExact value: -3720267 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | Unavailable Not reported for this period. | Unavailable Free cash flow cannot be calculated because Capital expenditure is unavailable for this period. |
| 2022 2021-10-01 – 2022-09-30 | −USD 4.88 million Exact valueExact value: -4884468 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | −USD 2.09 million Exact valueExact value: -2088304 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | Unavailable Not reported for this period. | Unavailable Free cash flow cannot be calculated because Capital expenditure is unavailable for this period. |
Capital expenditure uses the canonical mapped positive-spending convention. A missing, ambiguous, incompatible, or negative-sign input is left blank. Values use the latest reported version.
Coverage reflects filings processed into this Fundies dataset; it does not imply every source filing is loaded.
29 filings · 815 latest values · 815 originally reported values
Dataset published . Source filing dates and reporting periods are shown separately.
Identifiers: 0001109486, 1109486, EDXC, edgar:1109486
Also known as Endexx Corporation, Endexx Corp, Endexx Corporation, MICRON SOLUTIONS INC, PANAMED CORP